ERLOTINIB IN NON-SMALL CELL LUNG CANCER: ANALYSIS OF TOXICITY AND EFFICACY IN CLINICAL PRACTICE

被引：0
|
作者：
Alexandre, Maria Teresa A. [1 ]
Ip, Joana [1 ]
Duarte, Isabel [1 ]
Almodovar, Teresa [1 ]
Da Costa, Jose Duro [1 ]
机构：
[1] Inst Portugues Oncol Lisboa, Lisbon, Portugal
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
Lung cancer; Erlotinib; toxicity;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.24-054
引用
收藏
页码：S1326 / S1327
页数：2
相关论文
共 50 条
  • [41] Cutaneous complications of erlotinib in the treatment of non-small cell lung cancer
    Preda, V.
    Mann, S.
    Lee, S.
    HONG KONG JOURNAL OF DERMATOLOGY & VENEREOLOGY, 2008, 16 (03): : 133 - 141
  • [42] Correlation between erlotinib pharmacokinetics, cutaneous toxicity and clinical outcomes in patients with advanced non-small cell lung cancer (NSCLC)
    Tiseo, Marcello
    Andreoli, Roberta
    Gelsomino, Francesco
    Mozzoni, Paola
    Azzoni, Cinzia
    Bartolotti, Marco
    Bortesi, Beatrice
    Goldoni, Matteo
    Silini, Enrico Maria
    De Palma, Giuseppe
    Mutti, Antonio
    Ardizzoni, Andrea
    LUNG CANCER, 2014, 83 (02) : 265 - 271
  • [43] Use review of Erlotinib in advanced non-small cell lung cancer
    Alvarez-Payero, M.
    Ucha-Samartin, M.
    Martinez-Lopez-de-Castro, N.
    Campelo-Sanchez, E.
    Alvarez-Seoane, J.
    Vazquez-Lopez, C.
    Inaraja-Bobo, M. T.
    Perez Parente, D.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (02) : 438 - 438
  • [44] Intercalation of Erlotinib and Pemetrexed in the Treatment of Non-Small Cell Lung Cancer
    Li, Tianhong
    Lara, Primo N., Jr.
    Mack, Philip C.
    Perez-Soler, Roman
    Gandara, David R.
    CURRENT DRUG TARGETS, 2010, 11 (01) : 85 - 94
  • [45] Review of erlotinib in the treatment of advanced non-small cell lung cancer
    Ganjoo, Kristen N.
    Wakelee, Heather
    BIOLOGICS-TARGETS & THERAPY, 2007, 1 (04): : 335 - 346
  • [46] Erlotinib: a new therapeutic approach for non-small cell lung cancer
    Bonomi, P
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (08) : 1395 - 1401
  • [47] ERLOTINIB IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) TREATMENT
    Goncalves, Ivone M.
    Monteiro, Regina
    Neves, Sofia
    Conde, Sara
    Campainha, Sergio
    Parente, Barbara
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1298 - S1298
  • [48] From clinical trials to clinical practice: predictors of response to erlotinib in advanced non-small cell lung cancer patients pretreated with chemotherapy
    Mazzoni, Francesca
    Rotella, Virginia
    Pratesi, Nicola
    Boni, Luca
    Simi, Lisa
    Orlando, Claudio
    Comin, Camilla Eva
    Maddau, Cristina
    Di Costanzo, Francesco
    TUMORI JOURNAL, 2011, 97 (02): : 160 - 165
  • [49] Preoperative erlotinib in clinical stage I and II non-small cell lung cancer.
    Port, J. L.
    Yankelevitz, D.
    Lee, P. C.
    Spinelli, C.
    Altorki, N. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [50] The Efficacy and Toxicity of Gefitinib in Treating Non-small Cell Lung Cancer: A Meta-analysis of 19 Randomized Clinical Trials
    Wo, Hongmei
    He, Jing
    Zhao, Yang
    Yu, Hao
    Chen, Feng
    Yi, Honggang
    JOURNAL OF CANCER, 2018, 9 (08): : 1455 - 1465
12345